Sort
48,018 grants matching “immunotherapy”
Nano-therapeutics Reprogramming of Immunosuppressive Myeloid Cells Potentiate Radiotherapy for Glioblastoma
$358,680Peng Zhang · Northwestern University At Chicago · R37 · FY2023 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$358,680Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Development of B-cell-based vaccine for Glioblastoma
$358,680Catalina Lee Chang · Northwestern University At Chicago · R37 · FY2023 · CA
Vista, A Novel Checkpoint that Suppresses Anti-Tumor T Cell Responses
$358,678Li Lily Wang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease
$358,670Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2014 · NS
RAIT OF LUNG CANCER WITH RESIDUALIZING LABELS
$358,665Ctr For Molecular Medicine/Immunology · R01 · FY2000 · CA
Targeted Nanomedicines with Synergistic Chemotherapeutics to Enhance Immunotherapy of Metastatic Colorectal Cancer
$358,663Wenbin Lin · University Of Chicago · R01 · FY2019 · CA
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$358,637Shabaana A. Khader · Washington University · R01 · FY2020 · AI
Radiation Effect on Immune Cells and the Microbiome
$358,622Laura Santambrogio · Weill Medical Coll Of Cornell Univ · U54 · FY2022 · CA
Type I Interferon Pathway in Pancreatic Adenocarcinoma
$358,569Serge Y Fuchs · University Of Pennsylvania · R01 · FY2022 · CA
Type I Interferon Pathway in Pancreatic Adenocarcinoma
$358,569Serge Y Fuchs · University Of Pennsylvania · R01 · FY2023 · CA
Rewiring the myeloid cell response to adjuvants to improve tumor control
$358,566Michael James Gough · Providence Portland Medical Center · R01 · FY2024 · CA
UNC Food Allergy Initiative
$358,538Edwin Kim · Univ Of North Carolina Chapel Hill · U01 · FY2025 · AI
Osteoimmunology Core
$358,454Benjamin L Miller · University Of Rochester · P50 · FY2025 · AR
Water-soluble Abeta and its role in Alzheimer's disease
$358,446Dominic Martin Walsh · Brigham And Women'S Hospital · R01 · FY2016 · AG
DC exosome therapy to resolve inflammatory bone loss and oral infection
$358,435Ranya Elsayed · Augusta University · R01 · FY2024 · DE
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$358,434Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Virology Core
$358,431Thomas C. Friedrich · University Of Wisconsin-Madison · P01 · FY2018 · AI
T Cell Reagent Research for Monitoring T Cell in Food Allergy
$358,425Kari C. Nadeau · Stanford University · U01 · FY2020 · AI
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV
$358,401Beth Israel Deaconess Medical Center · R01 · FY2002 · AI
Microneedles for allergy immunotherapy
$358,370Harvinder Singh Gill · Texas Tech University · R01 · FY2018 · AI
INTERVENTION IN THE HYPERTROPHIC CYTOSKELETON
$358,359Columbia Univ New York Morningside · R01 · FY2001 · HL
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
$358,347Youli Zu · Methodist Hospital Research Institute · R01 · FY2019 · CA
A novel T-cell subset able to kill relapsed cancers
$358,347Qing Yi · Methodist Hospital Research Institute · R01 · FY2019 · CA
Defining Antigen Induced Immunoregulation in T1 Diabetes
$358,335University Of North Carolina Chapel Hill · R01 · FY2004 · AI